Nobuyuki Ohte Selected Research

Nobuyuki Ohte Research Topics

Disease

27	Heart Failure 01/2023 - 10/2003
15	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 02/2003
12	Hypertension (High Blood Pressure) 01/2022 - 05/2014
9	Myocardial Infarction 10/2023 - 06/2002
9	Atherosclerosis 11/2022 - 08/2002
8	Left Ventricular Dysfunction 01/2021 - 06/2005
7	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 01/2014
7	Thrombosis (Thrombus) 02/2018 - 03/2009
4	Pathologic Constriction (Stenosis) 01/2020 - 05/2016
4	Coronary Vasospasm (Coronary Artery Vasospasm) 08/2019 - 04/2015
4	Spasm (Spasms) 08/2019 - 04/2015
4	Death (Near-Death Experience) 10/2015 - 08/2003
3	Type 2 Diabetes Mellitus (MODY) 02/2024 - 01/2021
3	Myocarditis (Carditis) 01/2024 - 01/2018
3	Aortic Valve Stenosis (Aortic Stenosis) 11/2021 - 03/2010
3	Acute Coronary Syndrome 05/2021 - 01/2020
3	Chronic Renal Insufficiency 06/2017 - 04/2016
2	Disease Progression 03/2022 - 11/2020
2	Embolism (Embolus) 01/2021 - 07/2004
2	Stable Angina 01/2020 - 04/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2019 - 01/2018
2	Vascular Diseases (Vascular Disease) 05/2019 - 01/2016
2	Unstable Angina 10/2018 - 08/2017
2	Stroke (Strokes) 10/2018 - 08/2017
2	Inflammation (Inflammations) 09/2018 - 01/2014
2	Hematuria 12/2016 - 07/2004
2	Chest Pain (Chest Pains) 10/2016 - 04/2015
2	Aortic Aneurysm (Aneurysm, Aortic) 03/2016 - 01/2016
2	Dyslipidemias (Dyslipidemia) 01/2016 - 06/2012
2	Neoplasms (Cancer) 01/2016 - 01/2012
1	Cardiogenic Shock 01/2024
1	Necrosis 01/2024
1	Sepsis (Septicemia) 03/2022
1	Ventricular Fibrillation 01/2022
1	Ventricular Tachycardia 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Sudden Death 01/2022
1	Syncope (Fainting) 11/2021

Drug/Important Bio-Agent (IBA)

10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 05/2009
5	oxidized low density lipoproteinIBA 05/2021 - 08/2002
4	AlbuminsIBA 11/2021 - 01/2014
4	SaltsIBA 04/2021 - 01/2016
4	Angiotensin Receptor AntagonistsIBA 01/2018 - 03/2010
4	Warfarin (Coumadin)FDA LinkGeneric 12/2017 - 03/2010
4	Ergonovine (Ergometrine)IBA 01/2017 - 04/2015
4	omega-Chloroacetophenone (Mace)IBA 11/2016 - 09/2014
3	Troponin IIBA 10/2023 - 11/2019
3	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2012
3	C-Reactive ProteinIBA 01/2022 - 05/2009
3	Hemoglobins (Hemoglobin)IBA 11/2021 - 02/2008
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 04/2015
3	Malondialdehyde (Propanedial)IBA 01/2020 - 04/2015
3	AnticoagulantsIBA 02/2018 - 07/2004
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 07/2017 - 01/2012
2	TroponinIBA 01/2024 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2016
2	CanagliflozinIBA 01/2023 - 01/2021
2	Clopidogrel (Plavix)FDA Link 01/2021 - 01/2020
2	Prasugrel Hydrochloride FDA Link 01/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 08/2019 - 01/2016
2	ElementsIBA 05/2019 - 05/2012
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2018 - 11/2010
2	AdiponectinIBA 10/2018 - 10/2011
2	azilsartanIBA 01/2018 - 06/2017
2	azosemideIBA 07/2017 - 01/2012
2	Furosemide (Lasix)FDA LinkGeneric 07/2017 - 01/2012
2	DiureticsIBA 07/2017 - 01/2012
2	Nitroglycerin (Dynamite)FDA LinkGeneric 10/2016 - 04/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2016 - 01/2015
2	SodiumIBA 04/2016 - 07/2015
2	Serotonin (5 Hydroxytryptamine)IBA 03/2016 - 06/2012
2	HDL LipoproteinsIBA 01/2016 - 04/2015
2	HDL CholesterolIBA 01/2016 - 11/2003
2	LipidsIBA 04/2015 - 11/2010
2	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2012 - 06/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2010 - 12/2005
2	Natriuretic PeptidesIBA 02/2008 - 06/2005
1	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2024
1	ipragliflozinIBA 02/2024
1	glimepiride (Amarel)FDA LinkGeneric 01/2023
1	Uric Acid (Urate)IBA 11/2022
1	CalciumIBA 03/2022
1	Galectin 3 (LGALS3)IBA 11/2021
1	PTX3 proteinIBA 11/2021
1	Troponin T (Troponin T1)IBA 11/2021

Therapy/Procedure

17	Therapeutics 01/2022 - 07/2004
7	Catheters 01/2022 - 11/2007
6	Stents 08/2021 - 01/2014
6	Percutaneous Coronary Intervention 01/2021 - 04/2015
5	Renal Dialysis (Hemodialysis) 05/2021 - 08/2003
3	Drug Therapy (Chemotherapy) 11/2020 - 01/2013
3	Drug-Eluting Stents 01/2020 - 01/2014
2	Heart Transplantation (Grafting, Heart) 01/2024 - 01/2022
2	Cardiac Resynchronization Therapy 01/2022 - 08/2020
2	Extracorporeal Membrane Oxygenation 01/2022 - 01/2018
2	Denervation 01/2022 - 11/2017
2	Secondary Prevention 04/2021 - 10/2018
1	Heart-Assist Devices 01/2024